Sort
11,323 grants matching “glioblastoma”
"A PHASE I/II STUDIES OF BAY 43-9006 (SORAFENIB) IN COMBIN
$12,477Timothy Cloughesy · University Of California Los Angeles · M01 · FY2008 · RR
Characterization of oncogenic FGFR3-TACC3 fusion gene in glioblastoma
$12,450Wei Zhang · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
Role of SerpinA3 in the response of glioblastoma to cerebrospinal fluid
$12,442Hugo Guerrero-Cazares · Mayo Clinic Jacksonville · R03 · FY2019 · NS
Project 2: The GABP-TERT axis in immortality of Oligodendroglioma and Glioblastoma
$12,281Joseph F Costello · University Of California, San Francisco · P01 · FY2023 · CA
Project 3: Metabolic imaging of TERT expression
$12,281Sabrina Miriam Ronen · University Of California, San Francisco · P01 · FY2023 · CA
Project 4: Multi-modality Metabolic Imaging for Monitoring Molecular Sub-types of Glioma
$12,280Daniel B Vigneron · University Of California, San Francisco · P01 · FY2023 · CA
MR PERMEABILITY STUDIES IN A MOUSE XENOGRAFT MODEL OF GLIOBLASTOMA MULTIFORMA
$12,272Gerald Arthur Grant · Duke University · P41 · FY2011 · RR
Translational Studies of Fn14 in Brain Tumors
$12,115Nhan L Tran · Translational Genomics Research Inst · F32 · FY2007 · CA
Solid Tumor Therapeutics (Project-007)
$12,044Timothy J Eberlein · Washington University · P30 · FY2018 · CA
Program 2: Cancer Imaging Program (CIP)
$11,939Jennifer K. Barton · University Of Arizona · P30 · FY2019 · CA
Neuro-Oncology Program
$11,763Waldemar Debinski · Wake Forest University Health Sciences · P30 · FY2019 · CA
Identification and characterization of activated tyrosine kinases in glioblastoma
$11,757Jayne Stommel · Dana-Farber Cancer Inst · F32 · FY2008 · CA
UCLA IRB # 06-04-016 "PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH TEMOZ
$11,677Timothy Cloughesy · University Of California Los Angeles · M01 · FY2007 · RR
T1 OXYMETRY ON HIGH GRADE BRAIN TUMOR WITH ANTIANGIOGENIC THERAPY
$11,514Samira Guccione · Stanford University · P41 · FY2007 · RR
Glycocalyx and NCOR2-Notch-Mediated Stemness in Glioblastoma Aggressiveness
$11,443Yekaterina Andreevna Miroshnikova · University Of California, San Francisco · F31 · FY2015 · CA
Program 11: Cancer Immunology
$11,430Arlene H Sharpe · Dana-Farber Cancer Inst · P30 · FY2018 · CA
Defining mechanisms of extracellular communication for cancer therapy
$11,310Erwin G Van Meir · Emory University · R01 · FY2017 · CA
Mitochondrial quality control as a selective vulnerability in cancers with chromosome 10q deletion
$11,129Jacob Michael Winter · University Of Utah · F30 · FY2024 · CA
Program 2: Cancer Imaging Program (CIP)
$11,111Jennifer K. Barton · University Of Arizona · P30 · FY2018 · CA
Solid Tumor Therapeutics (Project-007)
$11,082Timothy J Eberlein · Washington University · P30 · FY2018 · CA
Project 2 - Clinical translation
$11,043Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2018 · CA
MOSAIC: Biospecimen Core
$11,020Kristin R Swanson · Mayo Clinic Arizona · U54 · FY2024 · CA
Inhibition of Brain Tumor Stem Cell Tumorigenicity using Self-assembling Nanogels
$11,016Maya Srikanth Graham · Northwestern University At Chicago · F30 · FY2012 · NS
Crosstalk between EGFR and TEAD Activity Directs Migration in Human Glioblastoma
$11,000Nadejda Mincheva Tsankova · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · NS
Role of Human Cerebrospinal Fluid Chemokines in the Invasiveness of Human Glioblastoma
$10,955Hugo Guerrero-Cazares · Mayo Clinic Jacksonville · R21 · FY2017 · CA